Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 339)
Posted On: 02/07/2021 3:28:36 PM
Post# of 36564
Posted By: MSc Coles
Re: Assiduous #26015
Hey Assiduous,

When you wrote "GNBT traded their 300 million NGIO common shares for 100,000 voting only special shares (300 million votes). The 300 million common shares went back into the NGIO treasury." Are you saying the 300 million common shares still exist? I was under the impression that they no longer existed, that they were "cancelled." What are you thoughts on this?

"On February 1, 2021, Generex Biotechnology Corporation (“GNBT”) and its majority owned public company NuGenerex Immuno-Oncology, Inc. (“NGIO”), agreed to l exchange three hundred million (300,000,000) of its NGIO common shares for one hundred thousand (100,000) shares of NGIO Series A Super Voting Preferred Stock (“NGIO Preferred Stock”)." https://www.sec.gov/Archives/edgar/data/10597...orm8k.htm)

"As a result of the share cancellation described above, NGIO has 100,300,000 shares of common stock outstanding of which GNBT owns 64,153,151 shares."
(https://www.sec.gov/Archives/edgar/data/1059784/000160706221000021/gnbt020221form8k.htm)













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site